CME Stock Options

CME Stock  USD 235.92  3.42  1.47%   
CME's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 0.29 with a put-to-call open interest ratio of 0.38 over 28 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 1.0, with calls trading at the volume of 14.0. This yields a 0.07 put-to-call volume ratio.

Open Interest Against April 17th 2025 Option Contracts

The chart above shows CME's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. CME's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for CME's option, there is no secondary market available for investors to trade.

CME Maximum Pain Price Across 2025-04-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as CME close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, CME's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on CME

Analyzing CME's in-the-money options over time can help investors to take a profitable long position in CME regardless of its overall volatility. This is especially true when CME's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money CME's options could be used as guardians of the underlying stock as they move almost dollar for dollar with CME's stock while costing only a fraction of its price.
CME's stock options are financial instruments that give investors the right to buy or sell shares of CME Group common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell CME stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If CME's stock price goes up or down, the stock options follow.
At present, CME's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting.

CME Group In The Money Call Balance

When CME's strike price is surpassing the current stock price, the option contract against CME Group stock is said to be in the money. When it comes to buying CME's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on CME Group are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

CME Current Options Market Mood

CME's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps CME Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most CME's options investors are not very successful. CME's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current CME contract

Base on the Rule 16, the options market is currently suggesting that CME Group will have an average daily up or down price movement of about 0.0181% per day over the life of the 2025-04-17 option contract. With CME trading at USD 235.92, that is roughly USD 0.0428. If you think that the market is fully incorporating CME's daily price movement you should consider buying CME Group options at the current volatility level of 0.29%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing CME options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" CME calls. Remember, the seller must deliver CME Group stock to the call owner when a call is exercised.

CME Option Chain

When CME's strike price is surpassing the current stock price, the option contract against CME Group stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
CME's option chain is a display of a range of information that helps investors for ways to trade options on CME. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for CME. It also shows strike prices and maturity days for a CME against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
CME250417C0022000010220.018.8 - 20.519.3In
Call
CME250417C0023000033230.011.8 - 12.813.4In
Call
CME250417C0024000090240.05.9 - 7.66.7Out
Call
CME250417C0025000087250.02.4 - 3.93.6Out
Call
CME250417C0026000095260.00.85 - 1.751.0Out
Call
CME250417C002700000270.00.0 - 2.552.55Out
Call
CME250417C002800000280.00.0 - 3.63.6Out
Call
CME250417C002900000290.00.0 - 2.22.2Out
Call
CME250417C003000000300.00.0 - 1.851.85Out
Call
CME250417C003100000310.00.0 - 2.152.15Out
Call
CME250417C003200000320.00.0 - 2.152.15Out
Call
CME250417C003300000330.00.0 - 2.152.15Out
Call
CME250417C003400000340.00.0 - 2.152.15Out
 Put
CME250417P002000001200.00.1 - 4.31.25Out
 Put
CME250417P002100008210.00.9 - 2.251.8Out
 Put
CME250417P0022000013220.02.1 - 3.43.4Out
 Put
CME250417P0023000083230.04.6 - 6.96.3Out
 Put
CME250417P0024000015240.09.0 - 10.69.8In
 Put
CME250417P002500000250.015.1 - 17.315.1In
 Put
CME250417P002600000260.023.0 - 26.723.0In
 Put
CME250417P002700000270.031.8 - 36.531.8In
 Put
CME250417P002800000280.041.8 - 46.541.8In
 Put
CME250417P002900000290.051.8 - 56.551.8In
 Put
CME250417P003000000300.061.7 - 66.561.7In
 Put
CME250417P003100000310.071.7 - 76.571.7In
 Put
CME250417P003200000320.082.0 - 86.582.0In
 Put
CME250417P003300000330.092.0 - 96.592.0In
 Put
CME250417P003400000340.0102.0 - 106.5102.0In

CME Market Cap Over Time

   Market Cap   
       Timeline  

CME Total Stockholder Equity

Total Stockholder Equity

17.55 Billion

At present, CME's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

CME Corporate Directors

Hilda PiellChief Human Resource Officer, Senior Managing DirectorProfile
Jack TobinChief Accounting Officer, Managing DirectorProfile
Derek SammannSenior Managing Director - Financial Products and ServicesProfile
Julie WinklerSenior Managing Director - Research and Product DevelopmentProfile
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.214
Dividend Share
4.55
Earnings Share
9.51
Revenue Per Share
16.795
Quarterly Revenue Growth
0.185
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.